A detailed history of Optiver Holding B.V. transactions in Mannkind Corp stock. As of the latest transaction made, Optiver Holding B.V. holds 1,795 shares of MNKD stock, worth $9,082. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,795
Previous 1,967 8.74%
Holding current value
$9,082
Previous $7,000 28.57%
% of portfolio
0.0%
Previous 0.0%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 10, 2025

SELL
$3.42 - $5.74 $588 - $987
-172 Reduced 8.74%
1,795 $9,000
Q2 2025

Aug 14, 2025

BUY
$3.71 - $5.04 $5,728 - $7,781
1,544 Added 365.01%
1,967 $7,000
Q1 2025

May 15, 2025

BUY
$4.92 - $6.6 $1,126 - $1,511
229 Added 118.04%
423 $2,000
Q4 2024

Feb 14, 2025

SELL
$5.93 - $7.44 $2,686 - $3,370
-453 Reduced 70.02%
194 $1,000
Q3 2024

Nov 14, 2024

SELL
$5.01 - $6.7 $9,478 - $12,676
-1,892 Reduced 74.52%
647 $4,000
Q2 2024

Aug 14, 2024

BUY
$4.05 - $5.43 $10,282 - $13,786
2,539 New
2,539 $13,000

Others Institutions Holding MNKD

About MANNKIND CORP


  • Ticker MNKD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 257,338,000
  • Market Cap $1.3B
  • Description
  • MannKind Corporation, a biopharmaceutical company, focuses on the development and commercialization of inhaled therapeutic products for endocrine and orphan lung diseases in the United States. It offers Afrezza, an inhaled insulin used to improve glycemic control in adults with diabetes. It also promotes Thyquidity to adult and pediatric endocri...
More about MNKD
Track This Portfolio

Track Optiver Holding B.V. Portfolio

Follow Optiver Holding B.V. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Optiver Holding B.V., based on Form 13F filings with the SEC.

News

Stay updated on Optiver Holding B.V. with notifications on news.